634Wire StoriesSumitomo Corporation Quantum Transformation (QX) Project Will Exhibit Online at SXSW2022
– Quantum Transformation, The Next Paradigm Shift. – TOKYO–(BUSINESS WIRE)–#QX–Sumitomo Corporation’s Quantum Transformation (QX) Project will present at the South by Southwest...
- 442Wire Stories
China Dabigatran Etexilate Market Research Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Dabigatran Etexilate Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Dabigatran Etexilate is an oral...
- 552Wire Stories
China Dabigatran Etexilate Market Research Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Dabigatran Etexilate Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Dabigatran Etexilate is an oral...
- 497Wire Stories
Research Report on China’s Levetiracetam Market, 2016-220 & 2021-2025: A First-Line Drug in the Field of Epilepsy Treatment, First Developed by UCB Under the Trade Name of Keppra – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Levetiracetam Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Levetiracetam was first developed by UCB...
- 489Wire Stories
Research Report on China’s Levetiracetam Market, 2016-220 & 2021-2025: A First-Line Drug in the Field of Epilepsy Treatment, First Developed by UCB Under the Trade Name of Keppra – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Levetiracetam Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Levetiracetam was first developed by UCB...
- 523Wire Stories
Research Report on China’s Alectinib Markets, 2016-2020 & 2021-2025: Originally Developed by Roche for Patients with the Zotinib-Resistant ALK-Positive Non-Small Cell Lung Cancer – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Alectinib Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Alectinib, originally developed by Roche, was...
- 516Wire Stories
Research Report on China’s Gefitinib Markets, 2016-2020 & 2021-2025: The World’s First Marketed EGFR-TKI, Originally Developed by AstraZeneca – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Gefitinib Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Gefitinib, originally developed by AstraZeneca, is...
- 652Wire Stories
Japan is World´s Number One Robot Maker – International Federation of Robotics Reports
iREX Tokyo started FRANKFURT, Germany & TOKYO–(BUSINESS WIRE)–Japan is the world´s number one industrial robot manufacturer – delivering 45% of the global...
- 496Wire Stories
Research Report on China’s Venlafaxine Markets, 2016-2020 & 2021-2025: The First Approved SNRI Inhibitor, Originally Developed by Wyeth, a Subsidiary of Pfizer, Under the Trade Name Effexor XR – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Research Report on China’s Venlafaxine Market, 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Venlafaxine was the first approved SNRI...
- 696Wire Stories
Investigation Report on China’s Tigecycline Markets, 2016-2020 & 2021-2025: A Broad-spectrum Glycyl Cyclic Peptide Antibiotic Administered Intravenously – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Tigecycline Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Tigecycline is a broad-spectrum glycyl cyclic...
